Deutsche Bank Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold; Risk/Reward Into Phase 3 GALNS

Go back to Deutsche Bank Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold; Risk/Reward Into Phase 3 GALNS
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 69.33 +2.34 (3.49%)
Previous Close $66.99    52 Week High $108.96 
Open $68.17    52 Week Low $62.12 
Day High $69.62    P/E N/A 
Day Low $67.75    EPS $-1.27 
Volume 1,976,615